Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Symptoms eating disorders

Fluoxetine Highly selective blockade of serotonin transporter (SERT) little effect on norepinephrine transporter (NET) Acute increase of serotonergic synaptic activity slower changes in several signaling pathways and neurotrophic activity Major depression, anxiety disorders panic disorder obsessive-compulsive disorder post-traumatic stress disorder perimenopausal vasomotor symptoms eating disorder (bulimia) Half-lives from 15-75 h oral activity Toxicity Well tolerated but cause sexual dysfunction Interactions Some CYP inhibition (fluoxetine 2D6, 3A4 fluvoxamine 1A2 paroxetine 2D6)... [Pg.670]

Anorexia Anorexia is loss of appetite. You may be familiar with the eating disorder, anorexia nervosa, in which the victim restricts dietary intake to starvation levels. Anorexia may be a symptom of acute or chronic exposure to certain chemicals. If you have suffered an unexplained loss of appetite in conjunction with other unusual symptoms, you may want to explore the MSDSs for chemicals that... [Pg.518]

Millions of people in the United States are affected by eating disorders. More than 90% of those afflicted are adolescents or young adult women. Although all eating disorders share some common manifestations, anorexia nervosa, bulimia nervosa, and binge eating each have distinctive symptoms and risks. [Pg.195]

There are data to confirm and reject the association of the Cys23Ser S-HT and the Gly22Ser 5-HTj receptor variants, characterized in vitro by reduced agonist potency, with phenotypes such as intractable suicidal ideation (98), ADHD (100), alcohol dependence, and schizophrenia (98,99,109-116). While the -1348 A/G polymorphism of the S-HT receptor has been associated with the negative symptoms of schizophrenia, other studies of eating disorders appear to be equivocal. A body of evidence is available, however, that S-HT variants may be associated with psychotic symptoms in Alzheimer s patients (94,100,117,118). [Pg.148]

When is medication indicated in the treatment of psychiatric illness There is no short answer to this question. At one end of the continuum, patients with schizophrenia and other psychotic disorders, bipolar disorder, and severe major depressive disorder should always be considered candidates for pharmacotherapy, and neglecting to use medication, or at least discuss the use of medication with these patients, fails to adhere to the current standard of mental health care. Less severe depressive disorders, many anxiety disorders, and binge eating disorders can respond to psychotherapy and/or pharmacotherapy, and different therapies can target distinct symptom complexes in these situations. Finally, at the opposite end of the spectrum, adjustment disorders, specific phobias, or grief reactions should generally be treated with psychotherapy alone. [Pg.8]

There are variants of the well-defined eating disorders mentioned above that often cause considerable distress and impairment. These are currently referred to as eating disorders not otherwise specified and are usually treated with strategies targeted towards their specific symptoms. [Pg.592]

In another study with desipramine, Agras et al. (1992) studied the effect of the drug, of individual CBT, and of the combination of the two and again found CBT to be superior to drug therapy alone, with no added benefit from using the combination to effect eating disorder symptoms. There was some evidence that the combination was superior for dietary restraint thinking. [Pg.599]

Given the current literature, antidepressant therapy should be initiated in youth with SUD and depression if the depressive symptoms persist during a period of abstinence, if such abstinence is unable to be achieved, or early in treatment if there is a history of recurrent depression. The efficacy of buproprion (Wellbutrin) in youth with SUD and depression is currently being explored (Solhkhah and Wilens, unpublished data). The antidepressants have little abuse potential and are generally very safe, although buproprion (Wellbutrin) should be avoided in youth with eating disorders or seizures. [Pg.613]

Psychological counseling is an important component of the treatment of eating disorders. The National Eating Disorders Association recommends treatment that is adapted to the individual. In that way, the person can address the causes and symptoms of the eating disorder. [Pg.161]

In a 2000 study of female athletes from gymnasiums, 40% reported symptoms of depression during withdrawal from AASs. Another finding was both AAS-using and nonusing women reported several unusual psychiatric syndromes, such as eating disorders, nontra-ditional gender roles, and chronic preoccupation with their physiques. [Pg.457]

Eating disorder that may be either a symptom or a syndrome. Manifested by insatiable hunger resulting in compulsive binge eating. [Pg.467]

Monitoring and referral criteria what signs and symptoms should you look out for which could indicate a patient may have an eating disorder ... [Pg.82]

The presence of eating problems in childhood or the appearance of a frank eating disorder in adolescence greatly increases the risk of having an eating disorder in adult life. In one Swedish series of 51 patients presenting with anorexia in their teens, 25% showed symptoms of an eating disorder when examined at age 24 (Rastam et al. 2003). However, half had appeared to have recovered completely. A fatal outcome is extremely rare. [Pg.136]


See other pages where Symptoms eating disorders is mentioned: [Pg.33]    [Pg.236]    [Pg.145]    [Pg.147]    [Pg.148]    [Pg.189]    [Pg.164]    [Pg.220]    [Pg.168]    [Pg.490]    [Pg.492]    [Pg.64]    [Pg.226]    [Pg.227]    [Pg.227]    [Pg.230]    [Pg.232]    [Pg.592]    [Pg.598]    [Pg.599]    [Pg.751]    [Pg.329]    [Pg.212]    [Pg.48]    [Pg.82]    [Pg.84]    [Pg.135]    [Pg.838]    [Pg.841]    [Pg.842]    [Pg.843]    [Pg.857]    [Pg.874]    [Pg.885]    [Pg.88]   


SEARCH



Eating

Eating disorders

© 2024 chempedia.info